Aberrant promoter methylation of HIV‐1 TAT‐interactive protein 2 (HTATIP2) attenuates the negative regulatory capacity of glioblastoma cells to reduce nuclear translocation of cancer‐relevant proteins such as the base excision repair enzyme N‐methylpurine DNA glycosylase (MPG). The gene discussed is HTATIP2; the disease is glioblastoma.